4
Changes in Ownership
Cogent Biosciences, Inc. Filed Acc 0000899243-22-024930
Options or other derivatives
- Director acquired 2,279 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Ferrante Karen Jean Director | 2022-07-01 | Grant or award · Stock Option (Right to Buy) | +2,279 | $5.87 | $13,379 | 2,279 | D |
Loading xslF345X03/doc4.xml…